 Carl White
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 26 | 2024 | 117 | 5.700 |
Why?
| | Chemical Warfare Agents | 24 | 2024 | 119 | 4.720 |
Why?
| | Inhalation Exposure | 18 | 2020 | 97 | 3.560 |
Why?
| | Lung | 35 | 2024 | 3561 | 2.610 |
Why?
| | Airway Obstruction | 7 | 2020 | 168 | 2.450 |
Why?
| | Isocyanates | 5 | 2022 | 14 | 2.130 |
Why?
| | Epithelial Cells | 18 | 2020 | 951 | 1.820 |
Why?
| | Thromboplastin | 5 | 2022 | 71 | 1.620 |
Why?
| | Fibrinolytic Agents | 4 | 2016 | 234 | 1.580 |
Why?
| | Tissue Plasminogen Activator | 3 | 2020 | 225 | 1.360 |
Why?
| | Hyperoxia | 7 | 2022 | 99 | 1.350 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 8 | 2013 | 225 | 1.350 |
Why?
| | Rats, Sprague-Dawley | 21 | 2021 | 2218 | 1.200 |
Why?
| | Chlorine | 6 | 2018 | 62 | 1.170 |
Why?
| | Mechlorethamine | 10 | 2020 | 63 | 1.160 |
Why?
| | Skin | 17 | 2015 | 655 | 1.160 |
Why?
| | Respiratory Insufficiency | 4 | 2018 | 290 | 1.140 |
Why?
| | Antioxidants | 10 | 2016 | 530 | 1.120 |
Why?
| | Blood Coagulation | 3 | 2018 | 218 | 1.120 |
Why?
| | Vascular Endothelial Growth Factor A | 8 | 2022 | 498 | 1.110 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2013 | 249 | 1.080 |
Why?
| | Rats | 22 | 2024 | 4958 | 1.030 |
Why?
| | Animals | 73 | 2024 | 31706 | 1.010 |
Why?
| | Bronchi | 6 | 2013 | 232 | 0.990 |
Why?
| | Oxidative Stress | 15 | 2016 | 1076 | 0.950 |
Why?
| | Hypoxia-Inducible Factor 1 | 4 | 2020 | 68 | 0.950 |
Why?
| | Thioredoxins | 4 | 2022 | 33 | 0.950 |
Why?
| | S-Adenosylmethionine | 5 | 2009 | 54 | 0.940 |
Why?
| | Respiratory Mucosa | 6 | 2017 | 251 | 0.940 |
Why?
| | Adenosine Triphosphate | 6 | 2015 | 430 | 0.930 |
Why?
| | Oxygen | 8 | 2022 | 854 | 0.890 |
Why?
| | Thioctic Acid | 3 | 2009 | 10 | 0.890 |
Why?
| | Antidotes | 8 | 2024 | 135 | 0.880 |
Why?
| | Ozone | 7 | 2020 | 99 | 0.840 |
Why?
| | Endothelium, Vascular | 6 | 2013 | 847 | 0.830 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2015 | 37 | 0.830 |
Why?
| | Acute Lung Injury | 2 | 2016 | 299 | 0.780 |
Why?
| | Procollagen-Proline Dioxygenase | 6 | 2007 | 26 | 0.760 |
Why?
| | Vaping | 1 | 2022 | 45 | 0.760 |
Why?
| | Air Pollutants | 3 | 2020 | 242 | 0.740 |
Why?
| | Neovascularization, Physiologic | 5 | 2013 | 173 | 0.740 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 71 | 0.740 |
Why?
| | Toxicity Tests | 2 | 2018 | 28 | 0.720 |
Why?
| | Acetylcholine | 2 | 2011 | 166 | 0.700 |
Why?
| | Cell Survival | 14 | 2014 | 1021 | 0.690 |
Why?
| | Prostate | 2 | 2011 | 156 | 0.680 |
Why?
| | Premature Birth | 4 | 2007 | 276 | 0.660 |
Why?
| | Reactive Oxygen Species | 6 | 2016 | 531 | 0.650 |
Why?
| | Transcriptome | 2 | 2022 | 725 | 0.630 |
Why?
| | Hydantoins | 1 | 2018 | 5 | 0.620 |
Why?
| | Muscle Contraction | 2 | 2011 | 389 | 0.600 |
Why?
| | Endothelial Cells | 5 | 2020 | 687 | 0.590 |
Why?
| | Air Pollution | 1 | 2020 | 169 | 0.580 |
Why?
| | Lung Diseases | 4 | 2017 | 701 | 0.580 |
Why?
| | DNA Damage | 9 | 2015 | 351 | 0.580 |
Why?
| | Blotting, Western | 10 | 2020 | 1147 | 0.530 |
Why?
| | Cell Line | 12 | 2022 | 2637 | 0.520 |
Why?
| | Cystic Fibrosis | 5 | 2011 | 955 | 0.520 |
Why?
| | Cells, Cultured | 16 | 2015 | 3886 | 0.520 |
Why?
| | Factor VII | 2 | 2012 | 26 | 0.510 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2020 | 329 | 0.510 |
Why?
| | Fibrinolysis | 2 | 2014 | 158 | 0.510 |
Why?
| | Trachea | 6 | 2018 | 224 | 0.500 |
Why?
| | Metalloporphyrins | 5 | 2016 | 103 | 0.500 |
Why?
| | Cell Hypoxia | 5 | 2013 | 221 | 0.490 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 590 | 0.490 |
Why?
| | Apoptosis | 13 | 2015 | 2363 | 0.480 |
Why?
| | Amino Acids, Dicarboxylic | 4 | 2020 | 11 | 0.480 |
Why?
| | S-Adenosylhomocysteine | 3 | 2009 | 24 | 0.470 |
Why?
| | Trans-Activators | 3 | 2005 | 367 | 0.460 |
Why?
| | Bronchitis | 1 | 2014 | 35 | 0.450 |
Why?
| | Disease Models, Animal | 11 | 2020 | 3535 | 0.450 |
Why?
| | Antifibrinolytic Agents | 1 | 2014 | 50 | 0.450 |
Why?
| | Household Articles | 1 | 2014 | 23 | 0.440 |
Why?
| | Thrombolytic Therapy | 1 | 2014 | 117 | 0.440 |
Why?
| | Disinfectants | 1 | 2014 | 34 | 0.440 |
Why?
| | Mesna | 2 | 2024 | 17 | 0.430 |
Why?
| | Male | 36 | 2022 | 55599 | 0.420 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 8 | 0.420 |
Why?
| | Heparin | 1 | 2014 | 224 | 0.410 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 21 | 0.410 |
Why?
| | Neutrophils | 3 | 2013 | 1176 | 0.410 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 916 | 0.410 |
Why?
| | Dermatitis, Contact | 4 | 2013 | 23 | 0.410 |
Why?
| | Cell Proliferation | 10 | 2017 | 2187 | 0.400 |
Why?
| | Time Factors | 13 | 2016 | 6116 | 0.400 |
Why?
| | Lipoproteins | 1 | 2013 | 159 | 0.400 |
Why?
| | Ethanolamines | 1 | 2012 | 19 | 0.400 |
Why?
| | Fibrin | 4 | 2013 | 65 | 0.390 |
Why?
| | Mice, Hairless | 15 | 2015 | 74 | 0.390 |
Why?
| | Cholinergic Agonists | 1 | 2011 | 7 | 0.390 |
Why?
| | Mecamylamine | 1 | 2011 | 7 | 0.390 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.390 |
Why?
| | Thinking | 1 | 2012 | 53 | 0.390 |
Why?
| | Budesonide | 1 | 2012 | 87 | 0.380 |
Why?
| | Nicotinic Antagonists | 1 | 2011 | 20 | 0.380 |
Why?
| | Heart Diseases | 1 | 2015 | 331 | 0.380 |
Why?
| | Muscarinic Antagonists | 1 | 2011 | 25 | 0.380 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2013 | 236 | 0.380 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.380 |
Why?
| | Lung Injury | 4 | 2017 | 198 | 0.370 |
Why?
| | DNA Methylation | 2 | 2006 | 495 | 0.370 |
Why?
| | Nasal Cavity | 1 | 2011 | 47 | 0.370 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 60 | 0.370 |
Why?
| | Asthma | 3 | 2020 | 2029 | 0.360 |
Why?
| | Vas Deferens | 1 | 2010 | 16 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2018 | 1842 | 0.350 |
Why?
| | Methionine | 2 | 2008 | 144 | 0.350 |
Why?
| | Bronchodilator Agents | 1 | 2012 | 239 | 0.350 |
Why?
| | Gases | 1 | 2010 | 37 | 0.350 |
Why?
| | Inflammation | 6 | 2022 | 2480 | 0.350 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2009 | 57 | 0.340 |
Why?
| | Administration, Inhalation | 5 | 2018 | 641 | 0.340 |
Why?
| | Humans | 50 | 2022 | 114689 | 0.330 |
Why?
| | Transcription Factors | 4 | 2010 | 1528 | 0.330 |
Why?
| | Receptors, Adenosine A2 | 1 | 2009 | 6 | 0.330 |
Why?
| | Models, Animal | 5 | 2017 | 344 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 398 | 0.320 |
Why?
| | Cell Cycle | 3 | 2010 | 542 | 0.310 |
Why?
| | Irritants | 3 | 2015 | 41 | 0.310 |
Why?
| | Environmental Exposure | 3 | 2020 | 372 | 0.310 |
Why?
| | Hypoxia | 3 | 2018 | 958 | 0.310 |
Why?
| | Mice | 27 | 2022 | 14869 | 0.310 |
Why?
| | Exocytosis | 2 | 2006 | 89 | 0.310 |
Why?
| | Lung Diseases, Interstitial | 1 | 2014 | 508 | 0.310 |
Why?
| | Respiratory Burst | 1 | 2008 | 28 | 0.300 |
Why?
| | Signal Transduction | 9 | 2022 | 4513 | 0.300 |
Why?
| | Infant, Premature | 3 | 2010 | 476 | 0.300 |
Why?
| | NADP | 1 | 2008 | 43 | 0.300 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 213 | 0.290 |
Why?
| | Papio | 6 | 2010 | 96 | 0.290 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2010 | 101 | 0.290 |
Why?
| | Deferoxamine | 1 | 2007 | 18 | 0.290 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 168 | 0.290 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1016 | 0.290 |
Why?
| | Suicidal Ideation | 1 | 2012 | 401 | 0.290 |
Why?
| | Bronchiolitis Obliterans | 2 | 2018 | 66 | 0.290 |
Why?
| | Immunohistochemistry | 8 | 2020 | 1629 | 0.280 |
Why?
| | Cobalt | 1 | 2007 | 46 | 0.280 |
Why?
| | Blister | 5 | 2014 | 43 | 0.280 |
Why?
| | MAP Kinase Signaling System | 3 | 2015 | 276 | 0.270 |
Why?
| | Folic Acid | 1 | 2008 | 161 | 0.270 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2022 | 119 | 0.270 |
Why?
| | Peroxidase | 9 | 2015 | 163 | 0.270 |
Why?
| | Phosphotransferases | 1 | 2006 | 25 | 0.260 |
Why?
| | Receptors, Purinergic | 1 | 2006 | 20 | 0.260 |
Why?
| | Tetrazolium Salts | 1 | 2006 | 18 | 0.260 |
Why?
| | Methionine Adenosyltransferase | 1 | 2005 | 10 | 0.260 |
Why?
| | Capillaries | 1 | 2006 | 91 | 0.260 |
Why?
| | Coloring Agents | 1 | 2006 | 72 | 0.250 |
Why?
| | Sputum | 2 | 2005 | 285 | 0.250 |
Why?
| | Thiazoles | 1 | 2006 | 110 | 0.250 |
Why?
| | Leukocyte Elastase | 1 | 2005 | 80 | 0.250 |
Why?
| | Enzyme Activation | 5 | 2013 | 785 | 0.250 |
Why?
| | Oxidation-Reduction | 7 | 2015 | 923 | 0.240 |
Why?
| | Recombinant Proteins | 4 | 2013 | 1230 | 0.240 |
Why?
| | Cytoprotection | 2 | 2015 | 51 | 0.230 |
Why?
| | Cell Line, Tumor | 6 | 2006 | 2710 | 0.230 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2018 | 124 | 0.230 |
Why?
| | Mental Disorders | 1 | 2012 | 892 | 0.230 |
Why?
| | Cytokines | 4 | 2016 | 1841 | 0.230 |
Why?
| | Capillary Permeability | 3 | 2015 | 139 | 0.230 |
Why?
| | Respiratory Function Tests | 5 | 2020 | 522 | 0.230 |
Why?
| | Phosphorylation | 8 | 2022 | 1569 | 0.230 |
Why?
| | Cystathionine | 1 | 2004 | 25 | 0.230 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2320 | 0.230 |
Why?
| | Cholesterol | 1 | 2006 | 367 | 0.230 |
Why?
| | Guanine | 1 | 2004 | 76 | 0.220 |
Why?
| | Sodium | 1 | 2024 | 183 | 0.210 |
Why?
| | Angiotensins | 1 | 2022 | 10 | 0.210 |
Why?
| | Hexokinase | 1 | 2002 | 10 | 0.210 |
Why?
| | Mesocricetus | 1 | 2022 | 29 | 0.210 |
Why?
| | Renin | 1 | 2022 | 31 | 0.210 |
Why?
| | Smoke | 1 | 2004 | 123 | 0.210 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 57 | 0.200 |
Why?
| | Limit of Detection | 2 | 2021 | 53 | 0.200 |
Why?
| | RNA, Small Interfering | 3 | 2013 | 535 | 0.200 |
Why?
| | Cricetinae | 1 | 2022 | 253 | 0.200 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 8 | 0.200 |
Why?
| | Microdissection | 2 | 2013 | 15 | 0.200 |
Why?
| | Pesticides | 1 | 2022 | 49 | 0.200 |
Why?
| | Silymarin | 2 | 2015 | 194 | 0.200 |
Why?
| | Cotinine | 1 | 2022 | 69 | 0.200 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 299 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2013 | 329 | 0.190 |
Why?
| | Liver | 1 | 2009 | 1637 | 0.190 |
Why?
| | Animals, Newborn | 5 | 2020 | 778 | 0.190 |
Why?
| | Erythrocytes | 2 | 2018 | 591 | 0.190 |
Why?
| | Mice, Knockout | 5 | 2022 | 2570 | 0.190 |
Why?
| | Prazosin | 2 | 2011 | 24 | 0.190 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 2 | 2011 | 18 | 0.190 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2021 | 470 | 0.180 |
Why?
| | Peptide PHI | 1 | 2020 | 4 | 0.180 |
Why?
| | Cobamides | 1 | 2020 | 19 | 0.180 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 306 | 0.180 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 449 | 0.180 |
Why?
| | Proteins | 3 | 2013 | 908 | 0.180 |
Why?
| | Immunoglobulin M | 2 | 2013 | 246 | 0.180 |
Why?
| | Cytotoxins | 1 | 2020 | 17 | 0.180 |
Why?
| | Pregnancy, Animal | 1 | 2020 | 52 | 0.180 |
Why?
| | Hemoglobins | 1 | 2022 | 315 | 0.170 |
Why?
| | Glutathione | 4 | 2011 | 293 | 0.170 |
Why?
| | Fibrosis | 1 | 2022 | 453 | 0.170 |
Why?
| | Nicotine | 1 | 2022 | 265 | 0.170 |
Why?
| | DNA-Binding Proteins | 4 | 2014 | 1314 | 0.170 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 448 | 0.170 |
Why?
| | Causality | 1 | 2020 | 103 | 0.170 |
Why?
| | Nitric Oxide Synthase Type II | 4 | 2014 | 157 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 412 | 0.160 |
Why?
| | Mice, Inbred C57BL | 8 | 2022 | 4694 | 0.160 |
Why?
| | In Vitro Techniques | 4 | 2020 | 1016 | 0.160 |
Why?
| | Societies, Medical | 2 | 2020 | 664 | 0.160 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 177 | 0.160 |
Why?
| | Liquid-Liquid Extraction | 1 | 2018 | 15 | 0.150 |
Why?
| | Methylation | 2 | 2009 | 208 | 0.150 |
Why?
| | Particulate Matter | 1 | 2020 | 185 | 0.150 |
Why?
| | DNA Repair | 2 | 2014 | 184 | 0.150 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2018 | 83 | 0.150 |
Why?
| | Enzyme Inhibitors | 3 | 2006 | 750 | 0.150 |
Why?
| | Lung Neoplasms | 3 | 2009 | 2177 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2015 | 445 | 0.150 |
Why?
| | Arterioles | 1 | 2017 | 39 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 797 | 0.140 |
Why?
| | Drug Interactions | 2 | 2011 | 338 | 0.140 |
Why?
| | Cardiac Output | 1 | 2018 | 143 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1140 | 0.140 |
Why?
| | Accidents, Occupational | 1 | 2017 | 14 | 0.140 |
Why?
| | Tomography, Optical Coherence | 1 | 2018 | 130 | 0.140 |
Why?
| | Cell Movement | 2 | 2013 | 869 | 0.140 |
Why?
| | DNA | 5 | 2010 | 1352 | 0.140 |
Why?
| | RNA, Messenger | 4 | 2009 | 2553 | 0.140 |
Why?
| | Biomarkers | 4 | 2022 | 3408 | 0.140 |
Why?
| | Necrosis | 2 | 2015 | 211 | 0.130 |
Why?
| | Alkylating Agents | 2 | 2013 | 27 | 0.130 |
Why?
| | Disaster Planning | 1 | 2017 | 74 | 0.130 |
Why?
| | Disasters | 1 | 2017 | 88 | 0.130 |
Why?
| | Calcium Signaling | 2 | 2015 | 217 | 0.130 |
Why?
| | Endoscopy | 1 | 2018 | 246 | 0.130 |
Why?
| | Cysteine | 2 | 2009 | 171 | 0.130 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 149 | 0.130 |
Why?
| | Polymerase Chain Reaction | 3 | 2013 | 993 | 0.130 |
Why?
| | Epidermis | 2 | 2014 | 149 | 0.120 |
Why?
| | Etiocholanolone | 1 | 2015 | 7 | 0.120 |
Why?
| | Cell Differentiation | 3 | 2017 | 1701 | 0.120 |
Why?
| | Age Factors | 2 | 2020 | 2894 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 86 | 0.120 |
Why?
| | Glucose | 3 | 2005 | 897 | 0.120 |
Why?
| | Ranolazine | 1 | 2015 | 22 | 0.120 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2018 | 323 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2765 | 0.120 |
Why?
| | alpha-2-Antiplasmin | 1 | 2014 | 3 | 0.120 |
Why?
| | Carboxypeptidase B2 | 1 | 2014 | 4 | 0.120 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 157 | 0.120 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 73 | 0.120 |
Why?
| | Blood-Air Barrier | 1 | 2014 | 10 | 0.120 |
Why?
| | Female | 16 | 2020 | 59511 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 512 | 0.120 |
Why?
| | Superoxides | 2 | 2022 | 214 | 0.120 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 119 | 0.120 |
Why?
| | Cloning, Molecular | 2 | 2007 | 522 | 0.120 |
Why?
| | Thrombosis | 1 | 2017 | 298 | 0.120 |
Why?
| | Drug Administration Routes | 1 | 2014 | 40 | 0.110 |
Why?
| | Pulmonary Ventilation | 1 | 2014 | 72 | 0.110 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 57 | 0.110 |
Why?
| | Kinetics | 2 | 2008 | 1551 | 0.110 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 20 | 0.110 |
Why?
| | Transcriptional Activation | 2 | 2013 | 337 | 0.110 |
Why?
| | Dermis | 1 | 2014 | 30 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 39 | 0.110 |
Why?
| | Intestine, Small | 1 | 2014 | 122 | 0.110 |
Why?
| | Respiration | 1 | 2014 | 180 | 0.110 |
Why?
| | Cell Death | 2 | 2012 | 323 | 0.110 |
Why?
| | Pulmonary Alveoli | 2 | 2020 | 373 | 0.110 |
Why?
| | Pregnancy | 4 | 2020 | 5518 | 0.110 |
Why?
| | Acidosis | 1 | 2014 | 88 | 0.110 |
Why?
| | Prothrombin | 1 | 2013 | 22 | 0.110 |
Why?
| | Receptors, Purinergic P1 | 1 | 2013 | 24 | 0.110 |
Why?
| | Indicators and Reagents | 1 | 2013 | 99 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 287 | 0.110 |
Why?
| | Spleen | 1 | 2014 | 487 | 0.100 |
Why?
| | Primary Cell Culture | 1 | 2013 | 149 | 0.100 |
Why?
| | Keratinocytes | 1 | 2014 | 216 | 0.100 |
Why?
| | Random Allocation | 3 | 2020 | 335 | 0.100 |
Why?
| | Inflammation Mediators | 2 | 2016 | 477 | 0.100 |
Why?
| | Cyclooxygenase 2 | 4 | 2015 | 164 | 0.100 |
Why?
| | Adenoviridae | 1 | 2013 | 184 | 0.100 |
Why?
| | Respiration, Artificial | 2 | 2007 | 529 | 0.100 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 718 | 0.100 |
Why?
| | Stem Cells | 1 | 2017 | 546 | 0.100 |
Why?
| | Fibrinogen | 1 | 2013 | 154 | 0.100 |
Why?
| | Formoterol Fumarate | 1 | 2012 | 7 | 0.100 |
Why?
| | Histones | 5 | 2015 | 535 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 343 | 0.100 |
Why?
| | Carbachol | 1 | 2011 | 21 | 0.100 |
Why?
| | Skin Diseases | 1 | 2013 | 122 | 0.100 |
Why?
| | Factor Xa | 1 | 2011 | 32 | 0.100 |
Why?
| | Benzofurans | 1 | 2011 | 18 | 0.100 |
Why?
| | Milk Proteins | 1 | 2011 | 36 | 0.100 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.090 |
Why?
| | Antigens, Surface | 1 | 2011 | 146 | 0.090 |
Why?
| | Pyrrolidines | 1 | 2011 | 55 | 0.090 |
Why?
| | Body Weight | 2 | 2014 | 869 | 0.090 |
Why?
| | Pneumonia | 1 | 2016 | 568 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1469 | 0.090 |
Why?
| | Cell Adhesion | 1 | 2012 | 432 | 0.090 |
Why?
| | GATA6 Transcription Factor | 1 | 2010 | 6 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 192 | 0.090 |
Why?
| | Thiourea | 1 | 2010 | 39 | 0.090 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 4 | 0.090 |
Why?
| | Child | 3 | 2020 | 18415 | 0.090 |
Why?
| | Atropine | 1 | 2010 | 25 | 0.090 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2010 | 4 | 0.090 |
Why?
| | Mitochondria | 2 | 2008 | 747 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 923 | 0.090 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 41 | 0.090 |
Why?
| | Wound Healing | 1 | 2012 | 258 | 0.090 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 140 | 0.090 |
Why?
| | Accidents | 1 | 2010 | 39 | 0.090 |
Why?
| | Comet Assay | 2 | 2014 | 18 | 0.090 |
Why?
| | Myocardium | 1 | 2015 | 913 | 0.090 |
Why?
| | Peptides | 1 | 2015 | 848 | 0.080 |
Why?
| | Models, Biological | 2 | 2008 | 1621 | 0.080 |
Why?
| | Dermatitis, Irritant | 1 | 2009 | 11 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 2010 | 144 | 0.080 |
Why?
| | Electric Stimulation | 1 | 2010 | 250 | 0.080 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2011 | 287 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 304 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 951 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 142 | 0.080 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 128 | 0.080 |
Why?
| | Response Elements | 1 | 2009 | 82 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Peroxides | 1 | 2008 | 20 | 0.080 |
Why?
| | Mitochondrial Membranes | 1 | 2008 | 32 | 0.080 |
Why?
| | Skinfold Thickness | 3 | 2013 | 49 | 0.080 |
Why?
| | Disulfides | 1 | 2008 | 90 | 0.080 |
Why?
| | Methyltransferases | 1 | 2008 | 61 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2010 | 282 | 0.070 |
Why?
| | Kidney | 1 | 2014 | 1188 | 0.070 |
Why?
| | Nanoparticles | 1 | 2011 | 313 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2010 | 5047 | 0.070 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2008 | 37 | 0.070 |
Why?
| | Occupational Exposure | 1 | 2010 | 255 | 0.070 |
Why?
| | RNA Interference | 1 | 2009 | 433 | 0.070 |
Why?
| | Calcium | 1 | 2013 | 1108 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 397 | 0.070 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2007 | 14 | 0.070 |
Why?
| | Demecolcine | 1 | 2006 | 2 | 0.070 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 103 | 0.070 |
Why?
| | DNA-Cytosine Methylases | 1 | 2006 | 5 | 0.070 |
Why?
| | Immediate-Early Proteins | 1 | 2007 | 52 | 0.070 |
Why?
| | Endoplasmic Reticulum | 1 | 2009 | 234 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 838 | 0.070 |
Why?
| | Mucins | 1 | 2007 | 61 | 0.070 |
Why?
| | United States | 2 | 2020 | 12183 | 0.070 |
Why?
| | Stilbenes | 1 | 2006 | 36 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2015 | 1144 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 551 | 0.070 |
Why?
| | Solubility | 1 | 2007 | 223 | 0.070 |
Why?
| | Adult | 3 | 2020 | 30550 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2008 | 1226 | 0.070 |
Why?
| | Arabidopsis Proteins | 1 | 2007 | 65 | 0.070 |
Why?
| | Receptors, Purinergic P2 | 1 | 2006 | 20 | 0.070 |
Why?
| | Fetus | 2 | 2010 | 700 | 0.070 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 184 | 0.070 |
Why?
| | Computer Systems | 1 | 2006 | 45 | 0.070 |
Why?
| | Arabidopsis | 1 | 2007 | 79 | 0.070 |
Why?
| | Apolipoprotein A-I | 1 | 2006 | 25 | 0.060 |
Why?
| | Bacterial Infections | 1 | 2008 | 218 | 0.060 |
Why?
| | Xanthine Oxidase | 1 | 2006 | 71 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 66 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 35 | 0.060 |
Why?
| | Vasa Vasorum | 1 | 2005 | 33 | 0.060 |
Why?
| | Brefeldin A | 1 | 2005 | 14 | 0.060 |
Why?
| | Cinnamates | 1 | 2005 | 10 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 181 | 0.060 |
Why?
| | Transduction, Genetic | 1 | 2005 | 113 | 0.060 |
Why?
| | Apyrase | 1 | 2005 | 14 | 0.060 |
Why?
| | Egtazic Acid | 1 | 2005 | 44 | 0.060 |
Why?
| | Oxygen Consumption | 1 | 2008 | 588 | 0.060 |
Why?
| | Pyrophosphatases | 1 | 2005 | 22 | 0.060 |
Why?
| | Deoxyglucose | 1 | 2005 | 43 | 0.060 |
Why?
| | Mucin-5B | 1 | 2007 | 183 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1131 | 0.060 |
Why?
| | Isoenzymes | 1 | 2005 | 283 | 0.060 |
Why?
| | Rad51 Recombinase | 2 | 2015 | 14 | 0.060 |
Why?
| | Hydrolysis | 1 | 2005 | 173 | 0.060 |
Why?
| | Administration, Cutaneous | 2 | 2015 | 117 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2022 | 1949 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 146 | 0.060 |
Why?
| | Sheep | 1 | 2007 | 764 | 0.060 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2005 | 129 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 164 | 0.060 |
Why?
| | Gene Expression | 1 | 2009 | 1421 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2005 | 162 | 0.060 |
Why?
| | Gestational Age | 1 | 2007 | 760 | 0.060 |
Why?
| | Amino Acids, Sulfur | 1 | 2004 | 8 | 0.060 |
Why?
| | Deoxyguanosine | 2 | 2015 | 26 | 0.060 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 849 | 0.060 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 281 | 0.060 |
Why?
| | Viscosity | 1 | 2003 | 81 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 796 | 0.060 |
Why?
| | Actins | 1 | 2005 | 381 | 0.050 |
Why?
| | Rheology | 1 | 2003 | 86 | 0.050 |
Why?
| | Adenosine | 1 | 2005 | 203 | 0.050 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 463 | 0.050 |
Why?
| | Elasticity | 1 | 2003 | 189 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2006 | 1083 | 0.050 |
Why?
| | Pronase | 1 | 2022 | 5 | 0.050 |
Why?
| | DNA, Single-Stranded | 1 | 2004 | 111 | 0.050 |
Why?
| | Edema | 2 | 2013 | 119 | 0.050 |
Why?
| | Electric Impedance | 2 | 2014 | 100 | 0.050 |
Why?
| | Carbamates | 1 | 2022 | 34 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 96 | 0.050 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2022 | 23 | 0.050 |
Why?
| | Carcinoma | 1 | 2004 | 198 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2004 | 214 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 483 | 0.050 |
Why?
| | Staining and Labeling | 1 | 2002 | 134 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2022 | 42 | 0.050 |
Why?
| | Macrophages, Peritoneal | 1 | 2002 | 93 | 0.050 |
Why?
| | Organ Size | 2 | 2014 | 436 | 0.050 |
Why?
| | Oxidants | 1 | 2002 | 112 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2002 | 248 | 0.050 |
Why?
| | Phenols | 1 | 2022 | 82 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2009 | 3003 | 0.050 |
Why?
| | Tyrosine | 1 | 2022 | 214 | 0.050 |
Why?
| | Pulmonary Surfactants | 1 | 2002 | 99 | 0.050 |
Why?
| | Phosphatidylcholines | 1 | 2002 | 133 | 0.050 |
Why?
| | Drug Stability | 1 | 2021 | 151 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 758 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 260 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2004 | 345 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2002 | 288 | 0.050 |
Why?
| | Serotonin | 1 | 2003 | 292 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 385 | 0.050 |
Why?
| | Injections, Intralesional | 1 | 2020 | 32 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 66 | 0.040 |
Why?
| | Injections, Intramuscular | 1 | 2020 | 116 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1578 | 0.040 |
Why?
| | Aldehydes | 2 | 2012 | 138 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 720 | 0.040 |
Why?
| | Disease Progression | 3 | 2014 | 2380 | 0.040 |
Why?
| | Endotoxins | 1 | 2020 | 211 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 768 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2007 | 2540 | 0.040 |
Why?
| | Mast Cells | 2 | 2011 | 116 | 0.040 |
Why?
| | Reference Values | 1 | 2020 | 743 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2020 | 407 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3346 | 0.040 |
Why?
| | Swine | 1 | 2020 | 700 | 0.040 |
Why?
| | Prenatal Care | 1 | 2020 | 253 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 82 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 40 | 0.040 |
Why?
| | Hypercapnia | 1 | 2018 | 51 | 0.040 |
Why?
| | Chemical Terrorism | 1 | 2017 | 5 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2018 | 153 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2017 | 94 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2017 | 80 | 0.030 |
Why?
| | Airway Remodeling | 1 | 2017 | 57 | 0.030 |
Why?
| | NF-kappa B | 2 | 2011 | 641 | 0.030 |
Why?
| | Interleukin-8 | 2 | 2011 | 237 | 0.030 |
Why?
| | Naphthalenes | 1 | 2017 | 38 | 0.030 |
Why?
| | Receptors, Notch | 1 | 2017 | 84 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 97 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2017 | 137 | 0.030 |
Why?
| | Epithelium | 1 | 2017 | 295 | 0.030 |
Why?
| | Skin Absorption | 1 | 2015 | 11 | 0.030 |
Why?
| | Mucus | 1 | 2015 | 54 | 0.030 |
Why?
| | Neuropeptides | 1 | 2015 | 65 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 911 | 0.030 |
Why?
| | Cell Lineage | 1 | 2017 | 309 | 0.030 |
Why?
| | Serum Albumin | 1 | 2015 | 137 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 139 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 113 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 11 | 0.030 |
Why?
| | Chemokines | 1 | 2015 | 216 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 104 | 0.030 |
Why?
| | Chromones | 1 | 2014 | 35 | 0.030 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 41 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1019 | 0.030 |
Why?
| | Boron Compounds | 1 | 2014 | 17 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 293 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| | Chemokine CXCL5 | 1 | 2013 | 12 | 0.030 |
Why?
| | Chemokine CXCL1 | 1 | 2013 | 68 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2015 | 270 | 0.030 |
Why?
| | Weight Loss | 1 | 2018 | 642 | 0.030 |
Why?
| | Morpholines | 1 | 2014 | 102 | 0.030 |
Why?
| | Erythema | 1 | 2013 | 25 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.030 |
Why?
| | Keratins | 1 | 2013 | 176 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 102 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2010 | 801 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2006 | 9088 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 542 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2013 | 227 | 0.030 |
Why?
| | Regeneration | 1 | 2013 | 160 | 0.020 |
Why?
| | Chromans | 1 | 2011 | 21 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1211 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 594 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2011 | 192 | 0.020 |
Why?
| | Buthionine Sulfoximine | 1 | 2010 | 7 | 0.020 |
Why?
| | Dermatitis | 1 | 2010 | 17 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 84 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 808 | 0.020 |
Why?
| | Alleles | 1 | 2013 | 789 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 502 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 63 | 0.020 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2010 | 88 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 573 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 107 | 0.020 |
Why?
| | Deoxyadenosines | 1 | 2009 | 7 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2009 | 26 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2009 | 30 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2014 | 591 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2010 | 141 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 1890 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2009 | 80 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 235 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2011 | 399 | 0.020 |
Why?
| | Oxidative Phosphorylation | 1 | 2009 | 155 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 138 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1518 | 0.020 |
Why?
| | Phenotype | 1 | 2013 | 2796 | 0.020 |
Why?
| | Adolescent | 1 | 2003 | 17848 | 0.020 |
Why?
| | RNA | 1 | 2010 | 809 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2004 | 292 | 0.010 |
Why?
| | Cattle | 1 | 2002 | 920 | 0.010 |
Why?
| | Monocytes | 1 | 2002 | 504 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2002 | 633 | 0.010 |
Why?
| | Infant | 1 | 2004 | 7963 | 0.010 |
Why?
|
|
White's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|